stockrow
Friday 6 November 2026
Export ARDT’s income statement to Excel — free account
Ardent Health, Inc.
ARDT Healthcare Medical Care Facilities
Ardent Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.3 billion, up 6.01% from fiscal 2024.
- Revenue
- +3.05%
- EPS
- +288.2%
- Free cash flow
- −23.5%
- Total debt
- −0.72%
Quarter to September 2026, against a year earlier
15.78
2.79
+21.48%
Follow ARDT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
9.10 | 9.01 | 17.89 | 9.94 |
P/S ratio |
0.20 | 0.19 | 0.22 | 0.23 | |
P/FCF ratio |
4.81 | 5.55 | 4.57 | 5.15 | |
P/Operating CF |
5.56 | (20.08) | 7.09 | 11.92 | |
P/B ratio |
0.74 | 0.70 | 0.80 | 0.81 | |
Price to Tangible BV |
1.73 | 1.58 | 1.79 | 1.73 | |
EV/Sales |
0.26 | 0.27 | 0.28 | 0.28 | |
EV/EBITDA |
3.36 | 3.38 | 4.16 | 4.19 | |
EV/Operating CF |
3.47 | 3.93 | 3.44 | 3.71 | |
EV/FCF |
6.31 | 7.84 | 5.81 | 6.33 | |
Quick Ratio |
1.33 | 1.36 | 1.45 | 1.40 | |
Current Ratio |
1.97 | 2.12 | 2.10 | 2.13 | |
Net Debt/EBITDA |
2.66 | 4.02 | 3.85 | 0.00 | |
Debt/Assets |
20.78% | 21.14% | 20.87% | 20.52% | |
Debt/Equity |
0.65 | 0.64 | 0.63 | 0.61 | |
Asset Turnover |
1.23 | 1.27 | 1.24 | 1.23 | |
Operating CF/Net income |
4.97 | (1.51) | 11.64 | 2.74 | |
Capex/Depreciation |
(2.01) | (0.64) | (0.92) | (1.17) | |
Interest Coverage |
8.46 | 6.63 | 4.44 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
77.17% | 77.85% | 79.13% | 0.00% | |
Intangible Assets out of Total Assets |
0.18 | 0.18 | 0.18 | 0.18 | |
Share Based Compensation of Revenue |
0.57% | 0.56% | 0.49% | 0.45% | |
Graham Net Nets |
(1.24) | (1.24) | (1.06) | (0.96) | |
Graham Number |
16.17 | 16.20 | 12.35 | 17.26 | |
Earnings Yield |
10.99% | 11.10% | 5.59% | 10.06% | |
Free Cash Flow Yield |
20.81% | 18.03% | 21.86% | 19.42% | |
Revenue per Share |
11.40 | 11.34 | 11.45 | 11.56 | |
Operating CF per Share |
1.59 | (0.43) | 1.39 | 0.87 | |
Capex per Share |
(0.60) | (0.20) | (0.27) | (0.35) | |
Free Cash Flow per Share |
0.99 | (0.63) | 1.12 | 0.52 | |
Cash per Share |
5.04 | 4.32 | 5.11 | 5.45 | |
Shareholders Equity per Share |
11.98 | 12.28 | 12.32 | 12.72 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.98 | 12.28 | 12.32 | 12.72 | |
Free Cash Flow |
139.44 | (88.31) | 158.06 | 73.12 | |
Working Capital |
1,012.28 | 1,068.66 | 1,078.55 | 1,153.10 | |
Capital Expenditures |
(83.99) | (28.09) | (38.68) | (48.81) | |
Net Current Asset Value |
(1,545.17) | (1,497.70) | (1,479.14) | (1,393.56) | |
EV/EBIT |
5.01 | 5.04 | 6.87 | 6.93 | |
Capex to Sales |
0.05 | 0.02 | 0.02 | 0.03 | |
Price to Operating Income |
3.82 | 3.56 | 5.41 | 5.64 | |
| Other line items | |||||
Average Receivables |
714.57 | 731.25 | 727.30 | 695.63 | |
Average Payables |
429.59 | 395.82 | 397.11 | 390.44 | |
Average Inventory |
116.84 | 120.10 | 117.21 | 115.85 | |
Average Assets |
5,123.15 | 5,082.04 | 5,153.67 | 5,253.70 | |
Average Common Equity |
1,603.71 | 1,649.82 | 1,697.09 | 1,711.17 |
Columns are period end dates · fundamentals updated 5 Nov 2026